Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children
NCT00123552Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2004
- Primary completion
- Jun 2006
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amodiaquine, artesunate, sulfadoxine, pyrimethamine, artemether in malaria, sponsored by University of California, San Francisco. Started Nov 2004; status: completed.
02
Drugs
amodiaquineartesunatesulfadoxinepyrimethamineartemether
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00123552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123552.